Vivita Technologies
Vivita Technologies, based in Woodland, CA, is at the forefront of the emerging tissue engineering and regenerative medicine market, leveraging its patented SPEAR Process to eliminate immunological barriers from animal-derived tissues. Their innovative biomaterial, the BARE Patch, is designed to be immune-compatible for human patients, providing a blueprint for regeneration.
The company's mission focuses on addressing the unmet clinical need for replacement tissues and organs by offering off-the-shelf, animal-derived biomaterial products. Vivita's regenerative solutions aim to integrate seamlessly with patients' own tissues post-implantation, offering a potential lifelong cure without the need for long-term medication or repeat transplants.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
